Skip to main content
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 8, Number 6, 2007

Articles

Favourites:
ADD

Targeting the Leukemia Microenvironment
pp. 685-701(17)
Authors: Konopleva, Marina; Andreeff, Michael

Favourites:
ADD

FLT3 as a Therapeutic Target in Childhood Acute Leukemia
pp. 703-714(12)
Authors: Stubbs, Matthew C.; Armstrong, Scott A.

Favourites:
ADD

Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
pp. 715-725(11)
Authors: Flotho, Christian; Kratz, Christian; Niemeyer, Charlotte M.

Favourites:
ADD

Targeting Transcription Factors in Acute Leukemia in Children
pp. 727-737(11)
Authors: Berman, Jason N.; Thomas Look, A.

Favourites:
ADD

The Cytoskeleton as a Therapeutic Target in Childhood Acute Leukemia:Obstacles and Opportunities
pp. 739-749(11)
Authors: E. Liaw, Tracy Y.; Y. Chang, Melissa H.; Kavallaris, Maria

Favourites:
ADD

Microarray-Based Identification of New Targets for Specific Therapies in Pediatric Leukemia
pp. 761-764(4)
Authors: den Boer, Monique L.; Pieters, Rob

Favourites:
ADD

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing
pp. 773-783(11)
Authors: Bachmann, Petra S.; Lock, Richard B.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content